Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary InterventionA Randomized Controlled Trial
Top Cited Papers
Open Access
- 26 June 2002
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 287 (24) , 3215-3222
- https://doi.org/10.1001/jama.287.24.3215
Abstract
Percutaneous coronary intervention (PCI) comprises a group of procedures that are used to relieve ischemic symptoms due to coronary atherosclerotic narrowing in patients with increasingly earlier stages of coronary heart disease (CHD). The most frequently performed PCI procedure is balloon angioplasty with or without stenting. In the United States, balloon angioplasty procedures increased nearly 4-fold between 1987 and 1999, and in 1999, 1.1 million angioplasty procedures, both with and without stent placement, were performed in the United States alone.1Keywords
This publication has 16 references indexed in Scilit:
- Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary InterventionCirculation, 2002
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001
- The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart diseaseInternational Journal of Cardiovascular Interventions, 2001
- Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrationsJournal of the American College of Cardiology, 1999
- A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty Final results of the fluvastatin angiographic restenosis (FLARE) trialEuropean Heart Journal, 1999
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patientsJournal of the American College of Cardiology, 1996
- Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgeryThe Lancet, 1995
- Lack of Effect of Lovastatin on Restenosis after Coronary AngioplastyNew England Journal of Medicine, 1994
- Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions.Circulation, 1994